| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2024 | AXGN Axogen, Inc. | Zaderej Karen L.80 | CEO | Sell | 39,280 | $7.68 | $301,670.40 | -1.1% | -11.2% | +131.0% | |
| Mar 21, 2024 | AXGN Axogen, Inc. | Scopelianos Angelo | Chief R&D Officer | Sell | 6,881 | $7.68 | $52,846.08 | -4.0% | -11.2% | +131.0% | |
| Mar 21, 2024 | AXGN Axogen, Inc. | Donovan Michael Patrick | VP Operations | Sell | 6,033 | $7.68 | $46,333.44 | -4.4% | -11.2% | +131.0% | |
| Mar 21, 2024 | AXGN Axogen, Inc. | Devinney Erick Wayne | Chief Innovation Officer | Sell | 4,578 | $7.68 | $35,159.04 | -0.9% | -11.2% | +131.0% | |
| Mar 20, 2024 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 3,863 | $0.34 | $1,316.12 | -0.3% | -35.1% | -22.7% | |
| Mar 20, 2024 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | CEO | Sell | 4,830 | $0.34 | $1,652.83 | -0.3% | -35.1% | -22.7% | |
| Mar 20, 2024 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 1,290 | $0.34 | $437.31 | -0.2% | -35.1% | -22.7% | |
| Mar 20, 2024 | AORT Artivion, Inc. | Stanton Marshall S.51 | SVP, Clinical &MD Affair | Sell | 2,183 | $20.39 | $44,511.37 | -2.6% | +12.0% | +16.9% | |
| Mar 19, 2024 | DXR Daxor Corp | Feldschuh Michael Richard75 | Chief Executive Officer | Buy | 647 | $8.15 | $5,273.05 | +0.3% | +5.2% | -1.4% | |
| Mar 19, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 2,147 | $1.19 | $2,554.93 | - | -5.0% | -40.5% | |
| Mar 19, 2024 | DCTH Delcath Systems, Inc. | Aharon Gil62 | Director | Buy | 26,882 | $3.72 | $100,001.04 | +2.6% | +80.6% | +217.3% | |
| Mar 19, 2024 | DCTH Delcath Systems, Inc. | Salamon Steven A J50 | Director | Buy | 26,882 | $3.72 | $100,001.04 | +2.5% | +80.6% | +217.3% | |
| Mar 19, 2024 | CTKB Cytek Biosciences, Inc. | Yan Ming77 | Chief Technology Officer | Sell | 40,000 | $6.74 | $269,600.00 | -0.3% | -15.2% | -37.0% | |
| Mar 18, 2024 | INSP Inspire Medical Systems, Inc. | Griffin Jerry C84 | Director | Sell | 554 | $193.53 | $107,215.62 | -2.6% | -17.8% | -18.5% | |
| Mar 18, 2024 | PRCT Procept Biorobotics Corp | Waters Kevin | EVP, CFO | Sell | 1,024 | $48.83 | $50,001.92 | -1.0% | +27.4% | +17.1% | |
| Mar 18, 2024 | OWLT Owlet, Inc. | Workman Kurt55 | Chief Executive Officer | Sell | 897 | $4.47 | $4,009.59 | -0.4% | +4.5% | -2.7% | |
| Mar 18, 2024 | COO Cooper Companies, Inc. | Ricupati Agostino62 | SVP &CAO | Sell | 54,724 | $100.89 | $5,521,230.23 | -68.3% | -8.3% | -20.6% | |
| Mar 18, 2024 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 14,506 | $66.45 | $963,929.50 | -20.0% | +13.3% | +47.6% | |
| Mar 18, 2024 | OWLT Owlet, Inc. | Scolnick Kathryn R.69 | Chief Financial Officer | Sell | 276 | $4.47 | $1,233.72 | -0.3% | +4.5% | -2.7% | |
| Mar 18, 2024 | PRCT Procept Biorobotics Corp | Shiblaq Hisham55 | EVP, Chief Comm. Officer | Sell | 244 | $48.83 | $11,914.52 | -0.4% | +27.4% | +17.1% | |
| Mar 18, 2024 | PRCT Procept Biorobotics Corp | Nouri Alaleh50 | EVP, CLO, Corp. Sec. | Sell | 441 | $48.83 | $21,534.03 | -0.7% | +27.4% | +17.1% | |
| Mar 18, 2024 | ATRC Atricure, Inc. | Dahlquist Karl S.69 | Chief Legal Officer | Sell | 1,885 | $32.16 | $60,621.60 | -3.6% | -37.8% | +6.2% | |
| Mar 18, 2024 | PRCT Procept Biorobotics Corp | Zadno Reza73 | President, CEO | Sell | 5,391 | $48.83 | $263,242.53 | -2.2% | +27.4% | +17.1% | |
| Mar 15, 2024 | BVS Bioventus Inc. | Church Katrina J52 | SVP &Chief Compliance Officer | Sell | 1,217 | $5.46 | $6,644.82 | -8.0% | +20.0% | +76.3% | |
| Mar 15, 2024 | SONX Sonendo, Inc. | Pudipeddi Vamsi Mohan Raj | Director | Buy | 800,000 | $0.10 | $80,000.00 | +74.5% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.